![Jens Altrichter](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jens Altrichter
Amministratore Delegato presso ARTCLINE GmbH
Profilo
Jens Altrichter is the founder.
He founded ARTCLINE GmbH in 2007 and currently holds the title of Chief Executive Officer & Managing Director.
Dr. Altrichter also worked as the Chief Operating Officer at LEUKOCARE AG from 2012 to 2019.
Posizioni attive di Jens Altrichter
Società | Posizione | Inizio |
---|---|---|
ARTCLINE GmbH
![]() ARTCLINE GmbH BiotechnologyHealth Technology ARTCLINE GmbH is a German biotechnology company that focuses on developing diagnostic and therapeutic procedures for intensive care medicine. The private company is located in Germany. | Amministratore Delegato | 01/01/2007 |
Precedenti posizioni note di Jens Altrichter
Società | Posizione | Fine |
---|---|---|
LEUKOCARE AG
![]() LEUKOCARE AG Medical/Nursing ServicesHealth Services LeukoCare AG develops protein stabilization and protection solutions. The firm specializes in the development of protein stabilization and protection solutions for biopharmaceuticals, vaccines, medical devices, and diagnostics technologies. Its service areas encompass technology licensing, prototyping and product development, clinical registration, biological and chemical testing, and consulting. The company was founded by Martin Scholz in 2001 and is headquartered in Munich, Germany. | Direttore operativo | 01/04/2019 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 2 |
---|---|
ARTCLINE GmbH
![]() ARTCLINE GmbH BiotechnologyHealth Technology ARTCLINE GmbH is a German biotechnology company that focuses on developing diagnostic and therapeutic procedures for intensive care medicine. The private company is located in Germany. | Health Technology |
LEUKOCARE AG
![]() LEUKOCARE AG Medical/Nursing ServicesHealth Services LeukoCare AG develops protein stabilization and protection solutions. The firm specializes in the development of protein stabilization and protection solutions for biopharmaceuticals, vaccines, medical devices, and diagnostics technologies. Its service areas encompass technology licensing, prototyping and product development, clinical registration, biological and chemical testing, and consulting. The company was founded by Martin Scholz in 2001 and is headquartered in Munich, Germany. | Health Services |
- Borsa valori
- Insiders
- Jens Altrichter